Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Deventer

Showing results (251-260 of 273) with videos related to

Pageof 28
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humansA Verbon, P E Dekkers, T ten Hove, et al.
Gastroenterology|September 29, 1999
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's diseaseP Rutgeerts, G D'Haens, S Targan, et al.
Inflammatory Bowel Diseases|October 18, 2007
Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cellsZuzana Zelinkova, Astrid J van Beelen, Floor de Kort, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administrationD Pajkrt, L Camoglio, M C Tiel-van Buul, et al.
The Journal of Clinical Investigation|January 1, 1994
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzeesM Levi, H ten Cate, K A Bauer, et al.
Brain Communications|October 27, 2021
Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous systemMarina Sogorb-Gonzalez, Carlos Vendrell-Tornero, Jolanda Snapper, et al.
The New England Journal of Medicine|June 7, 1990
Activation of coagulation after administration of tumor necrosis factor to normal subjectsT van der Poll, H R Büller, H ten Cate, et al.
World Journal of Gastroenterology|September 13, 2012
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitisSander van der Marel, Anna Majowicz, Karin Kwikkers, et al.
The New England Journal of Medicine|May 6, 1999
Infliximab for the treatment of fistulas in patients with Crohn's diseaseD H Present, P Rutgeerts, S Targan, et al.
Gastroenterology|October 1, 2003
Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in miceWouter J de Jonge, René M van den Wijngaard, Frans O The, et al.
Pageof 28

Showing results (251-260 of 273) with videos related to

Sort By:
Pageof 28
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humansA Verbon, P E Dekkers, T ten Hove, et al.
Gastroenterology|September 29, 1999
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's diseaseP Rutgeerts, G D'Haens, S Targan, et al.
Inflammatory Bowel Diseases|October 18, 2007
Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cellsZuzana Zelinkova, Astrid J van Beelen, Floor de Kort, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1997
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administrationD Pajkrt, L Camoglio, M C Tiel-van Buul, et al.
The Journal of Clinical Investigation|January 1, 1994
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzeesM Levi, H ten Cate, K A Bauer, et al.
Brain Communications|October 27, 2021
Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous systemMarina Sogorb-Gonzalez, Carlos Vendrell-Tornero, Jolanda Snapper, et al.
The New England Journal of Medicine|June 7, 1990
Activation of coagulation after administration of tumor necrosis factor to normal subjectsT van der Poll, H R Büller, H ten Cate, et al.
World Journal of Gastroenterology|September 13, 2012
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitisSander van der Marel, Anna Majowicz, Karin Kwikkers, et al.
The New England Journal of Medicine|May 6, 1999
Infliximab for the treatment of fistulas in patients with Crohn's diseaseD H Present, P Rutgeerts, S Targan, et al.
Gastroenterology|October 1, 2003
Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in miceWouter J de Jonge, René M van den Wijngaard, Frans O The, et al.
Pageof 28